Advertisement

Topics

[Series] The global problem of antifungal resistance: prevalence, mechanisms, and management

19:47 EDT 31 Jul 2017 | The Lancet

All serious fungal infections need appropriate antifungal therapy for successful patient outcome. Only a few classes of antifungal drugs are available, so the emergence of resistance to single drug classes and now multidrug resistance greatly hampers patient management. Azole resistance among Candida and Aspergillus species is one of the greatest challenges to clinical success, followed by echinocandin and multidrug resistance among some Candida species, especially Candida glabrata. The spread of agriculturally derived azole-resistant Aspergillus fumigatus and emerging threats such as multidrug resistant Candida auris are also alarming.

Original Article: [Series] The global problem of antifungal resistance: prevalence, mechanisms, and management

NEXT ARTICLE

More From BioPortfolio on "[Series] The global problem of antifungal resistance: prevalence, mechanisms, and management"

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...